Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Oncology

Are routine PET scans needed for follicular lymphoma?

At a Glance

If you are in remission from follicular lymphoma and feel fine, routine PET scans are not recommended. Studies show they do not improve survival but can cause false alarms and unnecessary radiation. Standard care relies on regular physical exams, blood tests, and monitoring for new symptoms.

If you are in remission from follicular lymphoma and feel perfectly fine, routine PET scans are not recommended. While it is completely normal to feel anxious or “under-monitored” without regular scans, leading cancer guidelines specifically advise against using them—as well as routine CT scans—for surveillance. Studies show that regular physical exams, blood work, and paying close attention to your body are just as effective at managing your long-term health, without the risks that come with frequent imaging [1][2].

Why Doctors Recommend Against Routine PET Scans

It might seem counterintuitive—shouldn’t we want to catch a relapse as early as possible? In some cancers, early detection on a scan changes everything. However, in follicular lymphoma, the evidence tells a different story. Here is why oncologists avoid routine PET scans during remission:

1. No Benefit to Overall Survival
Research shows that detecting a relapse “early” on a scan before you have any symptoms does not improve your overall survival or long-term outcome [1][3]. Follicular lymphoma is a slow-growing disease. If a scan detects a tiny, asymptomatic relapse, the standard medical approach is to return to “watch and wait” (also known as active surveillance) [4]. Treating an asymptomatic relapse based solely on a scan result does not work better than waiting until symptoms actually require treatment. In fact, most relapses (between 54% and 64%) are discovered because patients notice new symptoms or doctors find something during a physical exam, not because of a routine scan [1].

2. High Rate of False Positives
PET scans are incredibly sensitive. They detect areas in the body that are using a lot of energy. While cancer cells use high energy, so does simple inflammation, a minor infection, or even a healing muscle [5]. If you get a PET scan when you have no symptoms, there is a high chance it will light up for a completely benign (non-cancerous) reason. This can lead to unnecessary, invasive biopsies and extreme anxiety just to prove that you are still in remission [5][6].

3. The Burden of “Scanxiety”
Waiting for scan results is incredibly stressful. The medical community calls this scanxiety [7]. Going through this intense fear and dread every few months takes a massive toll on your mental health and quality of life. Since routine scans do not improve your medical outcome, doctors prefer to spare you this repeated psychological burden [7][8].

4. Cumulative Radiation Exposure
A single PET/CT scan delivers a significant dose of radiation—about 17 to 20.5 millisieverts (mSv) [9]. To put that in perspective, this is roughly equivalent to 170 to 200 standard chest X-rays. If you get routine scans multiple times a year for many years, this radiation adds up. Over time, repeated high-dose radiation exposure can slightly increase your risk of developing a secondary, unrelated cancer [10].

The Standard of Care for Monitoring Remission

Instead of routine imaging, the evidence-based standard of care for monitoring follicular lymphoma in remission typically involves appointments every 3 to 6 months for the first few years [2][1]. This schedule usually includes:

  • Routine Physical Exams: Your doctor will regularly feel for swollen lymph nodes in your neck, armpits, and groin, and check your abdomen to see if your spleen or liver is enlarged.
  • Blood Tests: Complete Blood Counts (CBC) and checking lactate dehydrogenase (LDH) levels help your care team monitor your internal health. LDH is an enzyme that acts as a marker of tissue damage and cell turnover. Even if you have internal lymph nodes swelling that the doctor cannot feel, changes in these blood markers and systemic symptoms provide reliable clues that warrant investigation.
  • Symptom Monitoring: You are the most important part of your monitoring team. Paying attention to your body and reporting new symptoms is highly effective.

When Is a PET Scan Necessary?

Your doctor will order a PET scan if they have a clinical reason to do so. If you develop new symptoms—such as unexplained weight loss, drenching night sweats, persistent fevers (fevers lasting more than a few days without a clear cause like a cold or flu), or a new, growing lump—a PET scan is an excellent tool to investigate what is happening and help guide a biopsy if needed [11][1]. Scans are used to investigate problems, not to go looking for them when you feel perfectly fine. Talk to your oncologist about your personalized follow-up schedule and exactly who to call if you notice any new changes.

Common questions in this guide

Why doesn't my oncologist want to do regular PET scans while I am in remission?
Routine PET scans are not recommended because they do not improve overall survival. They often result in false positives from minor inflammation or infections, causing unnecessary anxiety and invasive biopsies for things that are not cancer.
How will I know if my follicular lymphoma has relapsed without a scan?
Most relapses are discovered through physical exams, changes in blood work like LDH levels, or when a patient notices new symptoms. Paying attention to your body and attending regular check-ups is the safest and most effective way to monitor your remission.
What symptoms should prompt a PET scan during remission?
Your doctor will order a PET scan if you develop new 'red flag' symptoms. These include unexplained weight loss, drenching night sweats, persistent fevers without a clear cause, or a new, growing lump.
What is scanxiety?
Scanxiety refers to the intense fear and stress patients feel when waiting for imaging results. By avoiding unnecessary routine scans, doctors aim to spare you this repeated psychological burden while keeping you medically safe.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my specific follow-up schedule going to look like over the next one to three years?
  2. 2.If I develop symptoms between our scheduled appointments, who is the best person on your team to contact?
  3. 3.Are there any specific 'red flag' symptoms I should watch for given where my lymphoma was originally located?
  4. 4.Will my follow-up blood work look at specific markers like LDH, and how will those results be communicated to me?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Surveillance imaging during first remission in follicular lymphoma does not impact overall survival.

    Goldman ML, Mao JJ, Strouse CS, et al.

    Cancer 2021; (127(18)):3390-3402 doi:10.1002/cncr.33660.

    PMID: 34157780
  2. 2

    Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.

    Tobin JWD, Hapgood G, Johnston A, et al.

    Internal medicine journal 2024; (54(8)):1384-1395 doi:10.1111/imj.16454.

    PMID: 39099075
  3. 3

    Progression of disease within 24 months of initial therapy (POD24) detected incidentally in imaging does not necessarily indicate worse outcome.

    Bitansky G, Avigdor A, Vasilev E, et al.

    Leukemia & lymphoma 2020; (61(11)):2645-2651 doi:10.1080/10428194.2020.1786554.

    PMID: 32643497
  4. 4

    Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.

    Arushi Khurana , Mwangi R, Ansell SM, et al.

    Blood cancer journal 2021; (11(7)):133 doi:10.1038/s41408-021-00525-0.

    PMID: 34274939
  5. 5

    Emerging Role of FAPI PET Imaging for the Assessment of Benign Bone and Joint Diseases.

    Dondi F, Albano D, Treglia G, Bertagna F

    Journal of clinical medicine 2022; (11(15)) doi:10.3390/jcm11154514.

    PMID: 35956129
  6. 6

    PET/CT in Non-Hodgkin Lymphoma: An Update.

    Zanoni L, Bezzi D, Nanni C, et al.

    Seminars in nuclear medicine 2023; (53(3)):320-351 doi:10.1053/j.semnuclmed.2022.11.001.

    PMID: 36522191
  7. 7

    Scanxiety among Adults with Cancer: A Scoping Review to Guide Research and Interventions.

    Derry-Vick HM, Heathcote LC, Glesby N, et al.

    Cancers 2023; (15(5)) doi:10.3390/cancers15051381.

    PMID: 36900174
  8. 8

    Prevalence, severity, and modifiable predictors of scanxiety in patients undergoing routine oncologic imaging: a prospective longitudinal study.

    Shah MS, Memon JA, Malik U, et al.

    Clinical imaging 2025; (128()):110634 doi:10.1016/j.clinimag.2025.110634.

    PMID: 41077027
  9. 9

    ESTIMATION OF PATIENT ORGAN AND WHOLE-BODY DOSES IN [18F-FDG] PET/CT SCAN.

    Kessara A, Buyukcizmeci N, Gedik GK

    Radiation protection dosimetry 2023; (199(1)):61-68 doi:10.1093/rpd/ncac218.

    PMID: 36379473
  10. 10

    Effective dose and risk assessment in 18F-FDG PET/CT examinations of lymphoma patients using updated dose coefficients.

    Jafarian-Dehkordi F, Salimi Y, Jafari E, et al.

    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) 2026; (142()):105712 doi:10.1016/j.ejmp.2025.105712.

    PMID: 41570636
  11. 11

    miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.

    Thompson MA, Edmonds MD, Liang S, et al.

    Human pathology 2016; (50()):118-26.

    PMID: 26997445

This page explains general remission monitoring guidelines for follicular lymphoma and is for educational purposes only. Always consult your oncologist about your specific follow-up schedule and when imaging is necessary.

Get notified when new evidence is published on Follicular lymphoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.